On June 5, 2015 Oncolytics Biotech reported that its 2015 Annual Meeting of Shareholders will be held on Monday June 8th, 2015 at 2:30 pm CT (3:30 pm ET) at the Wyndham Grand Chicago Riverfront, 71 East Upper Wacker Drive, Chicago, Illinois (Press release, Oncolytics Biotech, JUN 5, 2015, View Source [SID:1234505235]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN as a potential cancer therapeutic.

A live audio webcast of the presentation will begin at approximately 3:00 pm CT (4:00 pm ET) and be available at: View Source;s=1&k=A26C8F4F6DCBD6F8AE9F2E855714E514 or on the company’s website at www.oncolyticsbiotech.com. It is recommended that listeners log on 10 minutes in advance of the presentation to register and download any necessary software.

An audio replay will be accessible following the presentation at View Source